Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SYL A
- Development stage
- Preclinical
- Lead developer
- Sylentis
- Modality
- Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
- Administration
- Ophthalmic
01
Overview
SYL A is an early-stage small interfering RNA (siRNA) therapeutic candidate developed by Sylentis, a subsidiary of PharmaMar, for the treatment of retinitis pigmentosa. Utilizing RNA interference (RNAi) technology, SYL A is designed to selectively silence the expression of a specific gene involved in the progression of retinal degeneration. The program is part of Sylentis's specialized ophthalmology pipeline, which focuses on using siRNA to treat various eye diseases. As of current pipeline disclosures, SYL A remains in the research and discovery phase, and its specific molecular target has not been publicly identified.
Beyond the preview
Go deeper on SYL A.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SYL A.